Hugh Sampson
Physician · Icahn School of Medicine at Mount Sinai
Credentials: · ·
History
Pediatrics
Research
Eosinophilic esophagitis: updated consensus recommendations for children and adults
Systematic review or meta-analysis · Journal of Allergy and Clinical Immunology · 2011 · 1,679 citations
Journal of Allergy and Clinical Immunology · 2006 · First of 26 authors · Corresponding · 1,465 citations
Fatal and near-fatal anaphylactic reactions to food in children and adolescents
New England Journal of Medicine · 1992 · First of 3 authors · 1,160 citations

120 papers

114 papers

78 papers

64 papers · 1 as a fellow

58 papers
- DF
47 papers

44 papers

43 papers
Grants
- 2005–2017
Immunobiology of Food Allergy and Its Treatment
National Institute of Allergy and Infectious Diseases · U19
Contact PI · $43.6M · Icahn School of Medicine at Mount Sinai
- 2009–2015
Mount Sinai Institutes for Clinical and Translational Sciences
National Center for Advancing Translational Sciences · UL1
Contact PI · $16.5M · Icahn School of Medicine at Mount Sinai
- 2009–2015
Mount Sinai Institutes for Clinical and Translational Sciences
National Center for Advancing Translational Sciences · KL2
Contact PI · $2.3M · Icahn School of Medicine at Mount Sinai
- 2009–2015
Mount Sinai Institutes for Clinical and Translational Sciences
National Center for Advancing Translational Sciences · TL1
Contact PI · $63.5K · Icahn School of Medicine at Mount Sinai
Clinical trials
- 2015–2016
Impact of Vaccination on Th2 Immunity in Infancy
Principal investigator · Terminated
National Institute of Allergy and Infectious Diseases (NIAID)
- 2013–2017
Oral Immunotherapy for Wheat Allergy
Principal investigator · Completed · Phase 1, Phase 2
Hugh A Sampson, MD
- 2012–2013
The Safety and Efficacy of a Peanut Immunotherapy Dissolving Film for Peanut Allergy
Principal investigator · Terminated · Phase 1, Phase 2
Johns Hopkins University
- 2007–2014
A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial
Principal investigator · Completed · Phase 1, Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
